- Exenatide exhibits anti‐inflammatory properties and modulates endothelial response to tumor necrosis factor α‐mediated activation
Cardiovascular Therapeutics · 2017
- Quantitative Testing of Prescriber Knowledge Regarding the Risks and Safe Use of Albiglutide
Drugs - Real World Outcomes · 2017
- Effects of glucagon‐like peptide‐1 receptor agonists on cardiovascular risk factors: A narrative review of head‐to‐head comparisons
Diabetes Obesity and Metabolism · 2017
- Antidiabetic Drug Alogliptin Protects the Heart Against Ischemia-reperfusion Injury Through GLP-1 Receptor-dependent and Receptor-independent Pathways Involving Nitric Oxide Production in Rabbits
Journal of Cardiovascular Pharmacology · 2017
- Effect of liraglutide on ectopic fat in polycystic ovary syndrome: <scp>A</scp> randomized clinical trial
Diabetes Obesity and Metabolism · 2017
- Glucagon-Like Peptide 1 Receptor Activation Augments Cardiac Output and Improves Cardiac Efficiency in Obese Swine After Myocardial Infarction
Diabetes · 2017
- Postprandial renal haemodynamic effect of lixisenatide vs once‐daily insulin‐glulisine in patients with type 2 diabetes on insulin‐glargine: An 8‐week, randomised, open‐label trial
Diabetes Obesity and Metabolism · 2017
- Association of glucagon‐like peptide‐1 receptor agonist use and rates of acute myocardial infarction, stroke and overall mortality in patients with type 2 diabetes mellitus in a large integrated health system
Diabetes Obesity and Metabolism · 2017
- Protective effect of glucagon-like peptide-1 agents on reperfusion injury for acute myocardial infarction: a meta-analysis of randomized controlled trials
Annals of Medicine · 2017
- Effects of the glucagon-like peptide-1 receptor agonist liraglutide on 24-h ambulatory blood pressure in patients with type 2 diabetes and stable coronary artery disease
Journal of Hypertension · 2017
- Differential effects of glucagon-like peptide-1 receptor agonists on heart rate
Cardiovascular Diabetology · 2017
- Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Therapy Adherence for Patients with Type 2 Diabetes in a Medicare Population
Advances in Therapy · 2017
- Heart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo-controlled trial
European Journal of Endocrinology · 2016
- GLP-1–Based Therapies Have No Microvascular Effects in Type 2 Diabetes Mellitus
Arteriosclerosis Thrombosis and Vascular Biology · 2016
- Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Cardiac Disorders
Annals of Pharmacotherapy · 2016
- Comparative cardiovascular safety of glucagon‐like peptide‐1 receptor agonists versus other antidiabetic drugs in routine care: a cohort study
Diabetes Obesity and Metabolism · 2016
- Acute renal haemodynamic effects of glucagon‐like peptide‐1 receptor agonist exenatide in healthy overweight men
Diabetes Obesity and Metabolism · 2015
- Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice
Diabetologia · 2015
- Design and rationale for the randomised, double-blinded, placebo-controlled Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS) crossover study
Cardiovascular Diabetology · 2015
- Dipeptidyl peptidase‐4 inhibition improves cardiac function in experimental myocardial infarction: Role of stromal cell‐derived factor‐1α
Journal of Diabetes · 2015
- The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study
Cardiovascular Diabetology · 2015
- Effects of the Once-Weekly Glucagon-Like Peptide-1 Receptor Agonist Dulaglutide on Ambulatory Blood Pressure and Heart Rate in Patients With Type 2 Diabetes Mellitus
Hypertension · 2014
- GLP-1R agonists for the prevention of cardiac injury in STEMI patients undergoing PCI: Something new and promising, or not?
IJC Metabolic & Endocrine · 2013
- Effects of glucagon-like peptide-1 receptor agonists on renal function
World Journal of Diabetes · 2013
- A Meta-Analysis of the Therapeutic Effects of Glucagon-Like Peptide-1 Agonist in Heart Failure
International Journal of Peptides · 2012